Group B patients maintained their serum IgM concentrations, which fell rapidly in those with more severe disease (Figure S6G), and their titers of anti-spike IgG and early neutralisation responses were comparable to patients progressing to more severe COVID-19 (Figures 5G and 5H). The gene discussed is CD40LG; the disease is COVID-19.